14,592
Views
31
CrossRef citations to date
0
Altmetric
Original Investigation

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis

, , , , &
Pages 586-601 | Received 04 Oct 2016, Accepted 16 Jan 2017, Published online: 07 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaoli Niu, Phani Veeranki, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, G. Rhys Williams & Antony Loebel. (2021) Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data. Current Medical Research and Opinion 37:5, pages 839-846.
Read now

Articles from other publishers (30)

Christine Zhang, Lillian Carter & Carrie J McAdams. (2023) Psychopharmacological considerations for comorbid anorexia nervosa and bipolar disorder. Psychiatry Research Case Reports 2:2, pages 100192.
Crossref
Fabiano A. Gomes, Henrique Dumay, Julia Fagen, Natalie Palma, Roumen Milev & Elisa Brietzke. (2023) Does the Ranking Matter? A Retrospective Cohort Study Investigating the Impact of the 2018 CANMAT and ISBD Guidelines for the Management of Patients with Bipolar Disorder Treatment Recommendations for Acute Mania on Rehospitalization Rates . The Canadian Journal of Psychiatry 68:8, pages 605-612.
Crossref
Fernando S Goes. (2023) Diagnosis and management of bipolar disorders. BMJ, pages e073591.
Crossref
Kouji Fukuyama, Eishi Motomura & Motohiro Okada. (2023) Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation. International Journal of Molecular Sciences 24:3, pages 2070.
Crossref
Masaya Ogasawara, Masahiro Takeshima, Yuichi Esaki, Yoshiyuki Kaneko, Tomohiro Utsumi, Yumi Aoki, Norio Watanabe, Masahiro Suzuki & Yoshikazu Takaesu. (2022) Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials. Neuropsychopharmacology Reports 42:4, pages 410-420.
Crossref
Alessandro Miola, Leonardo Tondo & Ross J. Baldessarini. (2022) Effects of Treatment of Acute Major Depressive Episodes in Bipolar I Versus Bipolar II Disorders With Quetiapine. Journal of Clinical Psychopharmacology 42:6, pages 530-535.
Crossref
Tom B. Mole, Yulia Furlong, Richard J. Clarke, Pradeep Rao, Julia K. Moore, Giulia Pace, Hugo Van Odyck & Wai Chen. (2021) Lurasidone for Adolescents With Complex Mental Disorders: A Case Series. Journal of Pharmacy Practice 35:5, pages 800-804.
Crossref
Hejian Tao, Jiawei Wang, Dong Shen, Fengli Sun & Weidong Jin. (2022) Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data. Frontiers in Psychiatry 13.
Crossref
Yuliang Hu, Huijuan Zhang, Hongyan Wang, Chris Wang, Simon Kung & Chunbo Li. (2022) Adjunctive antidepressants for the acute treatment of bipolar depression: A systematic review and meta-analysis. Psychiatry Research 311, pages 114468.
Crossref
Darryl Bassett, Philip Boyce, Bill Lyndon, Roger Mulder, Gordon Parker, Richard Porter, Ajeet Singh, Erica Bell, Amber Hamilton, Grace Morris & Gin S. Malhi. (2022) Guidelines for the management of psychosis in the context of mood disorders. Schizophrenia Research 241, pages 187-196.
Crossref
Melissa P. DelBello, Aditi Kadakia, Vincent Heller, Rajpal Singh, Katsuhiko Hagi, Tadashi Nosaka & Antony Loebel. (2022) Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression. Journal of the American Academy of Child & Adolescent Psychiatry 61:2, pages 243-254.
Crossref
N.N. Petrova. (2022) On the treatment of bipolar affective disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:1, pages 80.
Crossref
David Spelber, Jorge Almeida & Charles B. Nemeroff. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 325 350 .
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 247 304 .
Aditi Kadakia, Carole Dembek, Vincent Heller, Rajpal Singh, Jennifer Uyei, Katsuhiko Hagi, Tadashi Nosaka & Antony Loebel. (2021) Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis. BMC Psychiatry 21:1.
Crossref
Rikinkumar S. Patel, Nikhila Veluri, Jenil PatelRiddhi PatelTanya MachadoRasim Diler. (2021) Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis. Journal of Child and Adolescent Psychopharmacology 31:8, pages 521-530.
Crossref
Kouji Fukuyama & Motohiro Okada. (2021) Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43. International Journal of Molecular Sciences 22:11, pages 5623.
Crossref
Anees Bahji, Dylan Ermacora, Callum Stephenson, Emily R. Hawken & Gustavo Vazquez. (2020) Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis. The Canadian Journal of Psychiatry 66:3, pages 274-288.
Crossref
Deirdre Caffrey & Gillian L Sowden. (2020) A missed case of lurasidone induced laryngospasm: A case study and overview of extrapyramidal symptom identification and treatment. The International Journal of Psychiatry in Medicine 56:2, pages 73-82.
Crossref
Ruri Okubo, Toshiki Hasegawa, Kouji Fukuyama, Takashi Shiroyama & Motohiro Okada. (2021) Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy. Frontiers in Psychiatry 12.
Crossref
Motohiro Okada, Ryusuke Matsumoto, Yoshimasa Yamamoto & Kouji Fukuyama. (2021) Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor. International Journal of Molecular Sciences 22:3, pages 1351.
Crossref
Xiaoli Niu, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, Phani Veeranki, Michael Tocco & G. Rhys Williams. (2021) Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data. Current Therapeutic Research 94, pages 100629.
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide 457 464 .
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Monalisa Jena, Archana Mishra, Biswa Ranjan Mishra, Santanu Nath & Rituparna Maiti. (2020) Effect of lurasidone versus olanzapine on cardiometabolic parameters in unmedicated patients with schizophrenia: a randomized controlled trial. Psychopharmacology 237:11, pages 3471-3480.
Crossref
Anees Bahji, Dylan Ermacora, Callum Stephenson, Emily R. Hawken & Gustavo Vazquez. (2020) Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis. Journal of Affective Disorders 269, pages 154-184.
Crossref
Anna M. Wasik, Aleksandra Gorostowicz, Dominika Dudek, Jarosław Woroń & Marcin Siwek. (2020) Obesity and the pharmacotherapy of bipolar disorder. Pharmacotherapy in Psychiatry and Neurology 35:3-4, pages 177-192.
Crossref
Manish K. JhaJames W. Murrough. (2019) Psychopharmacology and Experimental Therapeutics for Bipolar Depression. FOCUS 17:3, pages 232-237.
Crossref
锐 金. (2019) Aripiprazole for Treatment of Bipo-lar Depression: Evidence-Based Medicine Study from Domestic Data. International Journal of Psychiatry and Neurology 08:01, pages 1-6.
Crossref
Jonathan ChanningMary MitchellSamuele Cortese. (2018) Lurasidone in Children and Adolescents: Systematic Review and Case Report. Journal of Child and Adolescent Psychopharmacology 28:7, pages 428-436.
Crossref